)
Visual24 Oct 2025
The rise of Alphabet
Mankind Pharma (MANKIND) investor relations material
Mankind Pharma Q1 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 25/26 earnings summary1 Aug, 2025
Executive summary
Q1 FY26 revenue rose 25% year-over-year to ₹3,574 crore, with EBITDA margin at 23.8% and strong performance in chronic, consumer, and export segments.
Outperformed Indian Pharma Market (IPM) in volume and value growth, especially in anti-infectives, respiratory, cardiology, and anti-diabetics.
Interim dividend of ₹1 per share approved to mark 30 years of operations.
Approved acquisition of Branded Generic Business (Women Health Rx Portfolio) from BSV and completed 100% stake acquisition in BSV.
Board approved raising up to ₹1,000 crore through unsecured funding instruments.
Financial highlights
Consolidated revenue from operations for Q1 FY26: ₹3,570 crore, up 24.5% year-over-year; EBITDA at ₹850 crore, up 25.8% year-over-year; EBITDA margin at 23.8%.
Gross margin at 70.5%, down 130 bps year-over-year due to unfavorable sales mix and inventory-related accruals.
Profit after tax at ₹445 crore, down 17.4% year-over-year due to higher finance and depreciation costs from BSC consolidation.
Cash flow from operations at ₹840 crore, up 54% year-over-year; net debt at ₹5,249 crore, net debt/EBITDA at 1.6x.
CapEx at ₹127 crore (3.6% of revenue), below 5% guidance.
Outlook and guidance
Maintains gross margin guidance above 70% and EBITDA margin guidance of 25–26% for FY26.
BSC/BSV sales growth guided at 18–20% with margins of 26–28%; international business expected to grow at mid-teens.
CapEx for FY26 expected below 5% of revenue, including biosimilar facility.
Tax rate guidance maintained at 20–21% for the year.
Confident in delivering healthy performance, supported by BSV growth and specialty expansion.
What is driving higher other expenses?
When will international approvals start for dydrogesterone?
Why did net profit decline 17.4% YOY?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Mankind Pharma earnings date
Q2 25/264 Nov, 2025
Next Mankind Pharma earnings date
Q2 25/264 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage